Danny (Dong Jun) Lee

Danny (Dong Jun) Lee has a diverse work experience in the field of pharmaceuticals and biologics. Danny (Dong Jun) is currently working at Adcentrx Therapeutics as a Director, a role they have held since February 2022. Prior to this, they were a Principal Investigator at the same company from June 2021 to February 2022.

Before joining Adcentrx Therapeutics, Danny worked at AbbVie for several years. Danny (Dong Jun) served as a Senior Scientist II, leading the design and chemical synthesis of biologically active molecules such as kinase inhibitors and PROTACs. Danny (Dong Jun) also played a key role in optimizing antibody-drug conjugates, focusing on linker-payload chemistry and bioconjugation. Danny (Dong Jun) held this position from January 2019 to June 2021. Earlier in their career at AbbVie, Danny was a Senior Scientist II, where they focused on the design and synthesis of drug-linkers for antibody-drug conjugates and tool compounds to widen the therapeutic index of these conjugates. Danny (Dong Jun) held this position from November 2017 to January 2019. Prior to that, they were a Senior Scientist I from February 2015 to November 2017.

Danny's work experience also includes a role as a Postdoctoral Scholar at the Stephen Kent group at the University of Chicago. In this position, they were hired by Reflexion Pharmaceuticals to develop a novel class of biologics called D-protein pharmaceuticals. Danny (Dong Jun) held this postdoctoral position from November 2011 to January 2015.

Additionally, Danny has worked as a Research Associate at the laboratory of Professor Margaret A. Brimble at The University of Auckland. In this role, they focused on developing scale-up strategies for short amylin peptide analogues. Danny (Dong Jun)'skey achievement was the successful scale-up of cyclic amylin peptide analogues using solid-phase peptide synthesis and chemoselective Ru-catalyzed ring-closing metathesis. Danny (Dong Jun) held this position from March 2011 to October 2011.

Danny (Dong Jun) Lee has a strong educational background in chemistry. Danny (Dong Jun) began their education in 1998 at Auckland Grammar Boys School, where they completed their high school education.

Danny (Dong Jun) then attended The University of Auckland, where they obtained a Bachelor of Science (BSc) degree in Organic Chemistry in 2005. In 2006, they continued their studies at The University of Auckland and completed a BSc Honours degree in Medicinal Chemistry.

Danny's pursuit of higher education led him to The University of Auckland once again, where they earned a Doctor of Philosophy (Ph.D.) in Chemistry in 2011. Danny (Dong Jun)'sresearch during this time likely focused on a specific area of chemistry.

After completing their Ph.D., Danny moved to the United States and attended the University of Chicago as a Postdoctoral Scholar. From 2012 to 2015, they conducted research in the field of Chemistry.

Overall, Danny's education journey showcases their passion for chemistry and their dedication to expanding their knowledge and expertise in the field.